Related Experiment Video

Updated: Aug 7, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Onychomycosis therapies: strategies to improve efficacy

Aditya K Gupta1, Linh Q Tu

  • 1Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Centre, (Sunnybrook Site), University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. agupta@execulink.com

Dermatologic Clinics
|June 27, 2006
PubMed

Insights

High rates of antifungal treatment failure and infection relapse necessitate improved therapeutic strategies. Combining existing therapies or modifying treatment regimens may enhance antifungal efficacy.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antifungal therapies face challenges with high treatment failure and infection relapse rates.
  • Existing treatment protocols may not be sufficient for all fungal infections.

Purpose of the Study:

  • To explore strategies for improving antifungal therapy efficacy.
  • To address the need for enhanced treatment outcomes in fungal infections.

Main Methods:

  • Review of current antifungal treatment regimens.
  • Analysis of combination therapy approaches.
  • Evaluation of potential modifications to treatment protocols.

Main Results:

  • Combination antifungal therapy shows promise for improved efficacy.
  • Modifying existing treatment regimens can potentially reduce relapse rates.
  • Further research is needed to optimize these strategies.

Conclusions:

  • Optimizing antifungal therapy delivery is crucial for improving patient outcomes.
  • Combining therapies and modifying regimens are key strategies to enhance antifungal efficacy and reduce relapse.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...